RecallRadar

FDA Device recall Z-2534-2024

Philips Azurion Interventional Fluoroscopic X-ray System with Software Version Number: R1.0, R1.1, R1.2- Intended for Image guidance in dia…

On 2024-08-14 the FDA classified a Class II recall of Philips Azurion Interventional Fluoroscopic X-ray System with Software Version Number: R1.0, R1.1, R1.2- Intended for Image guidance in dia… by Philips Medical Systems Nederland B V, citing potential Loss of Imaging (X-ray) Functionality and/or Longer Time to Perform Cold Restart.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2534-2024
ClassificationClass II
Statusongoing
Initiated2024-07-15
Published2024-08-14
Last updated2026-09-13 11:57 UTC
CompanyPhilips Medical Systems Nederland B V
DistributionUS

Product

Philips Azurion Interventional Fluoroscopic X-ray System with Software Version Number: R1.0, R1.1, R1.2- Intended for Image guidance in diagnostic, interventional, and minimally invasive surgery procedures for the following clinical application areas: vascular, non-vascular, cardiovascular, and neuro procedure. Model Numbers: 722063, 722064, 722067, 722068, 722078 and 722079

Reason

Potential Loss of Imaging (X-ray) Functionality and/or Longer Time to Perform Cold Restart

Identifiers

code_info
Model /UDI-DI: (1) 722063 (01)00884838085275(21); (2) 722064 (01)00884838085282(21); (3) 722067 (01)008848380853…Model /UDI-DI: (1) 722063 (01)00884838085275(21); (2) 722064 (01)00884838085282(21); (3) 722067 (01)00884838085350(21); (4) 722068 (01)00884838085367(21); (5) 722078 (01)00884838085251(21); (6) 722079 (01)00884838085268(21). Software Version Number: R1.0, R1.1, R1.2

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:57 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2534-2024%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.